StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by Str8Shuteron Aug 15, 2019 7:32pm

124 Views

Post# 30034395

RE:RE:RE:Oncore Pharma

Oh, yeeeaaaaaah. I'm loving it!! A very professional looking website, is my first impression. Taking a direct shot at competition (EXAS) by indirectly contrasting the more mainstream poop-in-a-box alternative!

ColonSentry® requires an in-office blood draw. It’s that simple!
ColonSentry does not require fasting, dietary restrictions, or special instructions.
ColonSentry does not require patients to provide or handle any stool samples.

Starting to get a little exciting now, folks! GLTA.